Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modern flow cytometry: a practical approach.

James W Tung1, Kartoosh Heydari, Rabin Tirouvanziam

  • 1Department of Genetics, School of Medicine, Stanford University, Stanford, CA 94305, USA.

Clinics in Laboratory Medicine
|July 31, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Peripheral Nerve Infiltration by CAR T-cells in a Case of Mononeuritis Multiplex after Ciltacabtagene Autoleucel.

Blood cell therapy·2026
Same author

Post CAR-T Measurable Residual Disease Monitoring in Mantle Cell Lymphoma Enables Early Detection of Disease Relapse.

American journal of hematology·2026
Same author

Randomized, Placebo-Controlled Trial of B-Cell Depletion for Prevention of Corticosteroid-Requiring Chronic Graft-Versus-Host Disease.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Dynamics of BCMA expression in patients with relapsed/refractory multiple myeloma receiving BCMA-directed CAR-T therapy.

Blood cancer journal·2026
Same author

Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS.

Blood advances·2026
Same author

Clinical and Cytokine Features of Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

Blood cancer discovery·2025
Same journal

Advances in Hemostasis Laboratory Testing.

Clinics in laboratory medicine·2026
Same journal

Extracellular Vesicles in Hemostasis.

Clinics in laboratory medicine·2026
Same journal

Thrombin Generation Assay: Ready for Prime Time.

Clinics in laboratory medicine·2026
Same journal

Viscoelastic Testing for the Laboratorian: Recent Advances and Practical Advice.

Clinics in laboratory medicine·2026
Same journal

Practical Recommendations for Harmonization of Hemostasis Testing Across Hospital Sites.

Clinics in laboratory medicine·2026
Same journal

The Role of Hypoxia in Vascular Endothelial Dysfunction and Venous Thromboembolism.

Clinics in laboratory medicine·2026
See all related articles

Fluorescence activated cell sorting (FACS) technology, initially used for monitoring HIV, now offers advanced applications. This article provides practical tips for users to enhance FACS quality and leverage new software developments.

Area of Science:

  • Immunology
  • Biotechnology
  • Medical Technology

Background:

  • CD T-cell counts, monitored using fluorescence activated cell sorting (FACS), were crucial for tracking HIV disease progression.
  • FACS technology has evolved with multicolor staining and sorting, enabling new therapeutic and clinical applications.

Purpose of the Study:

  • To provide current FACS users with practical approaches to improve their experimental quality.
  • To highlight the synergy between FACS technological advancements and emerging software support.

Main Methods:

  • The article outlines user-focused strategies for enhancing FACS quality.
  • It discusses leveraging modern FACS methodologies like multicolor staining and sorting.
  • It also touches upon the role of new software in supporting FACS applications.

Related Experiment Videos

Main Results:

  • The abstract implies that implementing these approaches can lead to improved FACS work quality.
  • It suggests that advancements in FACS technology and software are facilitating broader clinical and therapeutic uses.

Conclusions:

  • FACS technology has expanded beyond its initial HIV monitoring role.
  • Continuous technological development and software integration are key to unlocking new applications and improving quality in FACS.
  • Users can enhance their FACS outcomes through accessible strategies and by adopting new technological and software advancements.